AstraZeneca aims to get COVID-19 therapy into clinic in 2 months Lundbeck plotting up to 160 R&D job cuts as it rebuilds pipeline After 11 years, Sanofi kicks backs the rights to unwanted gene therapies to Oxford Biomedica Roche pens $2B biobucks pact with Innovent Biologics for bispecific and cell therapies BIO: Orchard CEO Gaspar on the company's 2020 pivot Lilly starts second COVID-19 antibody test with partner Junshi Biosciences, eyes combo trials Lycia Therapeutics uncloaks with $50M to tackle protein degradation in a new way Personalized cancer test maker ArcherDX files $100M IPO Researchers probe new drug strategies for keeping pancreatic cancer at bay Featured Story | Tuesday, June 9, 2020 AstraZeneca is planning to start a phase 1 clinical trial of a COVID-19 antibody therapy within two months. The commitment follows the signing of a deal that grants AstraZeneca an exclusive license to six anti-SARS-CoV-2 antibodies identified by researchers at Vanderbilt University. read more |
| |
|---|
|
Top Stories Tuesday, June 9, 2020 Lundbeck wants to rebuild its pipeline and sharpen focus on neuroscience in the coming years, and this will mean swinging the ax across its research organization. read more Monday, June 8, 2020 Oxford Biomedica is currently most well known for its work on COVID-19 vaccines and its tie-up with AstraZeneca, but a much older deal sits with French Big Pharma Sanofi. read more Tuesday, June 9, 2020 Roche is licensing out part of its cancer platform to Chinese biotech Innovent Biologics. read more Tuesday, June 9, 2020 In 2019, it was all systems go for Orchard Therapeutics. The company had pulled off a $200 million IPO, picked up GlaxoSmithKline’s stable of rare disease gene therapies and planned to break ground on a $90 million manufacturing site in California. Now, under the wing of a new CEO, the company has reined it in. read more Monday, June 8, 2020 In just over a week Eli Lilly has gone from having nothing in the clinic to not one but now two antibody drugs targeting SARS-CoV-2 as it also eyes combining both, and more besides, for a more potent affect. read more Tuesday, June 9, 2020 Having spent nearly a decade at NASH-focused NGM Bio, Aetna Wun Trombley knew it would take "something very special" to lure her away. That opportunity was Lycia Therapeutics, which is launching out of Versant Ventures with $50 million and technology from Stanford University to develop drugs that exploit protein degradation. read more Monday, June 8, 2020 An international pandemic notwithstanding, the cancer-focused genomic testing company ArcherDX is forging ahead with a $100 million IPO, following a busy month of pharma partnerships and FDA announcements. read more Monday, June 8, 2020 Inhibiting a protein called Slug could halt the spread of pancreatic cancer cells, a Sanford Burnham team reported, while scientists at the University of Cincinnati are using a nanodrug to improve the targeting of chemotherapy to pancreatic tumors. Both approaches aim to improve the prognosis for a cancer that's often not detected until it has spread. read more | | Your product is important, and your trial deserves the team that has what it takes. It takes knowledge. It takes passion. It takes commitment. It Takes Avania. Learn more. |
Enrollment Showcase | Sponsored by: University of Florida College of Pharmacy Position yourself as a precision medicine leader with the online graduate program in precision medicine. Learn the latest in genomic technologies and precision medicine therapies from experts in research and implementation. Join the future of health care with the flexibility and convenience of an online program. |
| |
|---|
|
Resources Sponsored by: ICON Download this whitepaper to learn more about the success factors that are required to keep a pandemic respiratory vaccine trial running at optimal speed and efficiency. Sponsored by: Catalent In a series of innovation sessions, Catalent RP Scherer softgel capsules were quickly identified as the ideal solution to drive incremental growth. Learn more. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper describing 7 keys to success for any biopharma company that is entering (or thinking about entering) Europe. Sponsored by: Clinical Ink This white paper covers a Phase III case study; BYOD advantages and misconceptions; and regulatory, copyright, and equivalency considerations. Sponsored by: Clinical Ink Learn how GI specific data capture solutions can support virtual and hybrid trials during COVID-19. Sponsored by: Copyright Clearance Center Dive into the history of biomedical classification and how these systems have evolved to address new technology and use cases. Presented by: ICON Clinical Research Download this whitepaper to learn more about the success factors that are required to keep a pandemic respiratory vaccine trial running at optimal speed and efficiency. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Sponsored by: Clarify Health Pharma launch teams spend significant resources on data and analytics with limited ROI. Read this case study to learn how a Life Sciences company identified two times more patients best suited for therapy, using Clarify’s deep and longitudinal patient and HCP insights. Sponsored by: Frontage Laboratories, Inc. Listen to our brand-new Frontage Laboratories podcast where you’ll take home tips for developing residual host cell proteins ELISA assay for biopharmaceutical products using commercial kits. Wednesday, May 20, 2020 | Time: 10am-3.30pm (BST) Join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss state of the art methods in early phase clinical research. Sponsored by: Oracle Health Sciences Patient-facing digital technologies are playing an important role in clinical trials for new drugs and medical devices, to the point where conducting virtual trials is becoming mainstream. But terms like remote trials, direct-to-patient trials, hybrid trials, decentralized trials, and more all add to the confusion of what makes a trial "virtual." Sponsored by: Outer Edge Technology Businesses must maintain pre-pandemic levels of productivity with smaller IT budgets. Learn why an effective Cloud Strategy is imperative for success in these unprecedented times. Medical Affairs Strategic Summit (MASS) East April 14-16, 2020 | New Brunswick, NJ PEGS Virtual Interactive Summit Virtual Event | June 2-26, 2020 European Healthcare Compliance Certificate Program June 2-5, 2020 | Paris, France BIO 2020 Now Fully Virtual: Announcing BIO Digital June 8-11, 2020 | Virtual Event Drug Development Boot Camp® 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training is in session. | Take your new medicine development skills to the next level. | 